News Snapshot:
In today’s briefing: - Ascendas REIT 3Q21 – Data Centres Could Unlock Re-Rating Opportunity - Idexx Laboratories (IDXX US): Multi-Year Visibility Through Razor and Blades Business Model - Shanghai Medicilon (688202.CH)- Concerns on Long-Term Outlook Despite Amazing Short Term Performance - EPG: Expect 2QFY22 Earnings to Came Down from a High Base - SAPPE: Expect 3Q21 Earnings to Reach the 4-Year High Related tickers: Ascendas Real Estate Investment Trust (AEMN.SI) , IDEXX Laboratories (IDXX.O) , Eastern Polymer Group (EPG.BK) , Sappe Pcl (SAPPE.BK) Before it’s here, it’s on Smartkarma